Proteolysis of Human Calcitonin in Excised Bovine Nasal Mucosa: Elucidation of the Metabolic Pathway by Liquid Secondary lonization Mass Spectrometry (LSIMS) and Matrix Assisted Laser Desorption lonization Mass Spectrometry (MALDI)

Pharmaceutical Research - Tập 13 Số 11 - Trang 1679-1685 - 1996
Lang, Steffen R.1, Staudenmann, Werner2, James, Peter2, Manz, Hans-Jörg3, Kessler, Rudolf3, Galli, Bruno4, Moser, Hans-Peter5, Rummelt, Andreas6, Merkle, Hans P.1
1Department of Pharmacy, Swiss Federal Institute of Technology Zurich (ETH)
2Department of Biology, Laboratory of Biochemistry, Swiss Federal Institute of Technology Zurich (ETH)
3Central Analytical Department, Ciba-Geigy AG
4Research and Development, Ciba-Geigy AG
5Central Analytical Department, Sandoz AG
6Research and Development, Sandoz AG

Tóm tắt

Purpose. Two calcitonins, i.e. human calcitonin (hCT) and, for comparison, salmon calcitonin (sCT), were chosen as peptide models to investigate nasal mucosal metabolism. Methods. The susceptibility of hCT and sCT to nasal mucosal enzymes was assessed by in-and-out reflection kinetics experiments in an in vitro model based on the use of freshly excised bovine nasal mucosa, with the mucosal surface of the mucosa facing the peptide solution. The kinetics of CT degradation in the bulk solution was monitored by HPLC. Peptide sequences of the main nasal metabolites of hCT were analyzed by using both liquid secondary ionization mass spectrometry (LSIMS), following HPLC fractionation of the metabolites, and matrix-assisted laser desorption ionization mass (MALDI) spectrometry. For sCT, the molecular weights of two major metabolites were determined by LC-MS with electrospray ionization. Results. Both CTs were readily metabolized by nasal mucosal enzymes. In the concentration range studied metabolic rates were higher with hCT than with sCT. Presence of endopeptidase activities in the nasal mucosa was crucial, cleaving both calcitonins in the central domain of the molecules. Conclusions. Typically, initial metabolic cleavage of hCT in nasal mucosa is due to both chymotryptic- and tryptic-like endopeptidases. The subsequent metabolic break-down follows the sequential pattern of aminopeptidase activity. Tryptic endopeptidase activity is characteristic of nasal sCT cleavage.

Từ khóa


Tài liệu tham khảo

citation_journal_title=Biochem. Biophys. Res. Comm.; citation_author=A. Hussain, J. Faraj, Y. Aramaki, J. E. Truelove.; citation_volume=133; citation_publication_date=1985; citation_pages=923-928; citation_id=CR1

citation_journal_title=Life Sci.; citation_author=M. A. Hussain, C. A. Koval, A. B. Shenvi, B. J. Aungst.; citation_volume=47; citation_publication_date=1990; citation_pages=227-231; citation_id=CR2

S. Lang, R. Oschmann, B. Traving, P. Langguth, and H. P. Merkle. (TP4), J. Pharm. Pharmacol., accepted for publication 1996

citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_author=D. F. Hunt, J. R. Yates, J. Shabanowitz, S. Winston, C. R. Hauer. ; citation_volume=83; citation_publication_date=1986; citation_pages=6233-6237; citation_id=CR4

citation_journal_title=Anal. Chem.; citation_author=M. Karas, F. Hillenkamp.; citation_volume=60; citation_publication_date=1988; citation_pages=2301-2303; citation_id=CR5

citation_journal_title=Pharm. Res.; citation_author=V. J. Wroblewsky, R. E. Kaiser, B. W. Becker.; citation_volume=10; citation_publication_date=1993; citation_pages=1106-1113; citation_id=CR6

F. Waldemeier, P. Graf, and M. Schär. Treffen Pharma-Peptide und Proteine, Zürich. (1993).

citation_journal_title=Eur. J. Clin. Pharmacol.; citation_author=A. E. Pontiroli, M. Alberetto, A. Calderara, E. Pajetta, G. Pozza. ; citation_volume=37; citation_publication_date=1989; citation_pages=427-430; citation_id=CR8

citation_journal_title=Calcif. Tissue Int.; citation_author=H. Kurose, Y. Seino, M. Shima, H. Tanaka., M. Ishida, K. Yamaopka, H. Yabuchi.; citation_volume=41; citation_publication_date=1987; citation_pages=249-251; citation_id=CR9

citation_journal_title=Proceed. Intern. Symp. Contr. Rel. Bioact. Mater.; citation_author=G. Ditzinger, J. Sandow, H. P. Merkle.; citation_volume=17; citation_publication_date=1990; citation_pages=220-221; citation_id=CR10

citation_journal_title=J. Biolog. Chem.; citation_author=T. Arvinte, A. Cudd, A. F. Drake.; citation_volume=268; citation_publication_date=1993; citation_pages=6415-6422; citation_id=CR11

citation_journal_title=J. Pharm. Sci.; citation_author=C. D. Yu, J. L. Fox, N. F. H. Ho, W. I. Higuchi.; citation_volume=68; citation_publication_date=1979; citation_pages=1347-1357; citation_id=CR12

citation_journal_title=J. Pharm. Biomed. Anal.; citation_author=R. H. Buck, F. Maxl.; citation_volume=8; citation_issue=8-12; citation_publication_date=1989; citation_pages=761-769; citation_id=CR13

citation_journal_title=Biol. Mass Spectrom.; citation_author=K. O. Börnsen, M. Schär, E. Gassmann.; citation_volume=20; citation_publication_date=1991; citation_pages=471-478; citation_id=CR14

citation_journal_title=Proceed. Intern. Symp. Control. Rel. Bioact. Mater.; citation_author=K. Morimoto, M. Miyazaki, H. Yamaguchi, M. Kakemi. ; citation_volume=19; citation_publication_date=1992; citation_pages=318-319; citation_id=CR15

citation_journal_title=Proceed. Intern. Symp. Control. Rel. Soc.; citation_author=M. Dohi, Y. Nishibe, Y. Makino, Y. Suzuki.; citation_volume=P; citation_publication_date=1993; citation_pages=9; citation_id=CR16